Context: Diabetes remission is frequent after biliopancreatic diversion (BPD) in morbidly obese patients with type 2 diabetes (T2D). Data, mechanisms, and clinical indications in nonobese T2D patients are scanty.
Objective:The objective of the study was to assess remission and investigate insulin sensitivity and -cell function after BPD in nonobese patients with long-standing T2D.Design, Setting, and Patients: This was a clinical research study comparing 15 T2D patients (aged 55 Ϯ 1 years, duration of 16 Ϯ 2 years, body mass index of 28.3 Ϯ 0.6 kg/m 2 , glycosylated hemoglobin 8.6% Ϯ 1.3%) with 15 gender-, age-, and body mass index-matched nondiabetic controls. Before surgery and 2 months and 1 year later, a 3-hour oral glucose tolerance test, a 5-hour mixed-meal test, and a 3-hour euglycemic clamp were performed.
Intervention:The intervention included a BPD (distal gastrectomy, proximal ileum anastomosed to remaining stomach, biliopancreatic limb anastomosed to ileum 50 cm from the ileocecal valve).Results: Glycemia improved in all patients, but remission (glycosylated hemoglobin Ͻ 6.5% and normal oral glucose tolerance test) occurred in 6 of 15 patients. Insulin resistance (19.8 Ϯ 0.8 mol ⅐ min Ϫ1 ⅐ kg ffm Ϫ1 , P Ͻ .001 vs 40.9 Ϯ 5.3 of controls) resolved already at 2 months (34.2 Ϯ 2.8) and was sustained at 1 year (34.7 Ϯ 1.6), although insulin-mediated suppression of endogenous glucose production remained impaired.
Conclusions:In nonobese patients with long-standing T2D, BPD improves metabolic control but induces remission in only approximately 40% of patients. Peripheral insulin sensitivity is restored early after surgery and similarly in remitters and nonremitters, indicating a weight-independent effect of the operation. The initial extent of -cell incompetence is the main predictor of the metabolic outcome.
Bariatric surgery has powerful effects to improve glucose metabolism (1, 2) and has been associated with reduced rates of type 2 diabetes (T2D) (3), cardiovascular events (4), and mortality (5, 6). Detailed metabolic studies have shown that adjustable gastric banding (7, 8), Rouxen-Y gastric bypass (9, 10), biliopancreatic diversion (11)(12)(13)(14), and ileal transposition (15) all enhance both insulin action and -cell function more effectively than conven-